Curanex Pharmaceuticals Inc (CURX)

Curanex Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Sep 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	220	-	-	-
Enterprise Value	220	-	-	-
Quick Ratio	1.03	10.22	5.21	-
Current Ratio	3.61	35.54	5.21	-
Return on Equity (ROE)	-196.72%	-128.32%	-54.60%	-
Return on Assets (ROA)	-	-61.28%	-28.51%	-
Return on Capital (ROIC)	-60.60%	-64.42%	-34.30%	-
Buyback Yield / Dilution	-3084.84%	-2109.84%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q